{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:48:16Z","timestamp":1789987696500,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473278"],"award-info":[{"award-number":["81473278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703596"],"award-info":[{"award-number":["81703596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cbi.2019.108745","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T01:58:54Z","timestamp":1562637534000},"page":"108745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3"],"prefix":"10.1016","volume":"310","author":[{"given":"Dandan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108745_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1440-1746.1998.tb00707.x","article-title":"From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament","volume":"13","author":"Makino","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108745_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.cbi.2019.108745_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2019.108745_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2019.108745_bib5","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.3390\/ijms13078882","article-title":"Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode","volume":"13","author":"Kotb","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2019.108745_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1440-1681.12490","article-title":"Effect of common polymorphisms of the farnesoid X receptor and bile acid transporters on the pharmacokinetics of ursodeoxycholic acid","volume":"43","author":"Hu","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cbi.2019.108745_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1099-0801(199611)10:6<313::AID-BMC603>3.0.CO;2-F","article-title":"Separation and detection of bile acid 3-glucuronides in human urine by liquid chromatography\/electrospray ionization\u2013mass spectrometry","volume":"10","author":"Ikegawa","year":"1996","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cbi.2019.108745_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0039-128X(98)00002-6","article-title":"Separation and characterization of carboxyl-linked glucuronides of bile acids in incubation mixture of rat liver microsomes","volume":"63","author":"Goto","year":"1998","journal-title":"Steroids"},{"key":"10.1016\/j.cbi.2019.108745_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.08.013","article-title":"LC\/ESI-tandem mass spectrometric determination of bile acid 3-sulfates in human urine: 3\u03b2-Sulfooxy-12\u03b1-hydroxy-5\u03b2-cholanoic acid is an abundant nonamidated sulfate","volume":"846","author":"Goto","year":"2007","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cbi.2019.108745_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/hep.21576","article-title":"Why bile acid glucuronidation is a minor pathway for conjugation of endogenous bile acids in man","volume":"45","author":"Hofmann","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2019.108745_bib11","first-page":"1222","article-title":"Glucuronidation of bile acids by their high-dose infusion into rats","volume":"13","author":"Takikawa","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2019.108745_bib12","series-title":"Exchangers","first-page":"205","article-title":"Organic anion-transporting polypeptides","author":"Stieger","year":"2014"},{"key":"10.1016\/j.cbi.2019.108745_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1248\/bpb.b14-00767","article-title":"Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs","volume":"38","author":"Maeda","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2019.108745_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/mp050063u","article-title":"Uptake of ursodeoxycholate and its conjugates by human hepatocytes:\u2009 role of Na+-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and OATP1B3 (OATP8)","volume":"3","author":"Maeda","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2019.108745_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.fct.2013.11.028","article-title":"Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates","volume":"64","author":"Wang","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2019.108745_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj1290197","article-title":"The graphical determination of Km and Ki","volume":"129","author":"Dixon","year":"1972","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.108745_bib17","first-page":"10","article-title":"Substitutes for bear bile for the treatment of liver diseases: Research progress and future perspective","volume":"2016","author":"Li","year":"2016","journal-title":"J. Evidence-Based Complementary Altern. Med."},{"key":"10.1016\/j.cbi.2019.108745_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-8741(95)01249-D","article-title":"Ethnopharmacology of bear gall bladder: I","volume":"47","author":"Li","year":"1995","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2019.108745_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-4804(85)90024-1","article-title":"Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid","volume":"38","author":"MacDonald","year":"1985","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cbi.2019.108745_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/HMER.S91709","article-title":"Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection","volume":"8","author":"Bowlus","year":"2016","journal-title":"Hepatic Med. Evid. Res."},{"key":"10.1016\/j.cbi.2019.108745_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up","volume":"30","author":"Leuschner","year":"1985","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cbi.2019.108745_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2019.108745_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2019.108745_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2019.108745_bib25","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-008-0600-8","article-title":"Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort","volume":"54","author":"Kotb","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cbi.2019.108745_bib26","first-page":"1495","article-title":"Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid","volume":"22","author":"Kuiper","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108745_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2133\/dmpk.22.125","article-title":"Genetic polymorphism of bile acid coa: amino acid N-acyltransferase in Japanese individuals","volume":"22","author":"Tougou","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cbi.2019.108745_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/00498254.2010.519407","article-title":"Genetic polymorphisms of glycine N-acyltransferase (GLYAT) in a French caucasian population","volume":"40","author":"Lino Cardenas","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2019.108745_bib29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1517\/17425255.2013.796929","article-title":"Glycine conjugation: importance in metabolism, the role of glycine N-acyltransferase, and factors that influence interindividual variation","volume":"9","author":"Badenhorst","year":"2013","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2019.108745_bib30","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108745_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2019.108745_bib32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.21362","article-title":"Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver","volume":"44","author":"Trottier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2019.108745_bib33","first-page":"189","article-title":"Serum concentrations of bile acid glucuronides in hepatobiliary diseases","volume":"27","author":"Takikawa","year":"1983","journal-title":"Digestion"},{"key":"10.1016\/j.cbi.2019.108745_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2019.108745_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00498254.2011.618954","article-title":"Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues","volume":"42","author":"Court","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2019.108745_bib36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.108745_bib37","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine","volume":"275","author":"Strassburg","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.108745_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1006\/bbrc.2000.3064","article-title":"Immunochemical identification of UGT isoforms in human small bowel and in caco-2 cell monolayers","volume":"273","author":"Paine","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2019.108745_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/138920011795101877","article-title":"NSAID acyl glucuronides and enteropathy","volume":"12","author":"Urs","year":"2011","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2019.108745_bib40","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1021\/acs.jafc.6b01872","article-title":"Metabolic activation of rhein: insights into the potential toxicity induced by rhein-containing herbs","volume":"64","author":"Yuan","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cbi.2019.108745_bib41","series-title":"Drug-Induced Liver Disease","first-page":"35","article-title":"Mechanistic role of acyl glucuronides","author":"Horng","year":"2013"},{"key":"10.1016\/j.cbi.2019.108745_bib42","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/jf9033317","article-title":"Effects of illicit dexamethasone upon hepatic drug metabolizing enzymes and related transcription factors mrnas and their potential use as biomarkers in cattle","volume":"58","author":"Giantin","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cbi.2019.108745_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1742-7843.2012.00865.x","article-title":"Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP","volume":"111","author":"K\u00f6nig","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2019.108745_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/mp050063u","article-title":"Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8)","volume":"3","author":"Maeda","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2019.108745_bib45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1152\/physiol.00020.2008","article-title":"The role of FXR in disorders of bile acid homeostasis","volume":"23","author":"Eloranta","year":"2008","journal-title":"Physiology"},{"key":"10.1016\/j.cbi.2019.108745_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0030-1253225","article-title":"Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis","volume":"30","author":"Wagner","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cbi.2019.108745_bib47","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acs.molpharmaceut.6b01103","article-title":"Transcriptional regulation of human UDP-glucuronosyltransferase 2B10 by farnesoid X receptor in human hepatoma HepG2 cells","volume":"14","author":"Lu","year":"2017","journal-title":"Mol. Pharm."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718316120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718316120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:49:41Z","timestamp":1778633381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718316120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"alternative-id":["S0009279718316120"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108745","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108745"}}